Literature DB >> 31620848

Imaging of pediatric cutaneous melanoma.

Sue C Kaste1,2.   

Abstract

Melanoma accounts for 7% of all cancers in adolescents ages 15-19 years but is an unexpected malignancy in younger children. The prevalence of malignant melanoma is very rare in children ages 1-4 years, but certain non-modifiable risk factors such as xeroderma pigmentosum, congenital melanocytic nevus syndrome and other inherited traits increase the risk for its development in these young children. Recent genomic studies have identified characteristics of pediatric melanoma that differ from conventional melanoma seen in adults. In this review the authors inform on the types of melanoma seen in children and adolescents, discuss similarities and differences in melanoma between children and adults, and discuss the role of imaging in the care of these children.

Entities:  

Keywords:  Adolescents; Children; Computed tomography; Magnetic resonance imaging; Malignancy; Melanoma; Risk factors; Skin; Ultrasonography

Year:  2019        PMID: 31620848     DOI: 10.1007/s00247-019-04374-9

Source DB:  PubMed          Journal:  Pediatr Radiol        ISSN: 0301-0449


  100 in total

1.  NRAS mutation is the sole recurrent somatic mutation in large congenital melanocytic nevi.

Authors:  Christelle Charbel; Romain H Fontaine; Gabriel G Malouf; Arnaud Picard; Natacha Kadlub; Nizar El-Murr; Alexandre How-Kit; Xiaoping Su; Aurore Coulomb-L'Hermine; Jorg Tost; Samia Mourah; Selim Aractingi; Sarah Guégan
Journal:  J Invest Dermatol       Date:  2013-10-15       Impact factor: 8.551

2.  Lymphoscintigraphy and sentinel lymph node biopsy, in cutaneous melanoma staging and treatment decisions.

Authors:  Ljiljana Jaukovic; Goran Sijan; Milica Rajović; Lidija Kandolf-Sekulovic; Marija Radulovic; Zeljko Mijuskovic; Lidija Zolotarevski; Boris Ajdinovic; Marijan Novakovic
Journal:  Hell J Nucl Med       Date:  2015-07-20       Impact factor: 1.102

Review 3.  Melanoma patient imaging in the era of effective systemic therapies.

Authors:  M Stodell; J F Thompson; L Emmett; R F Uren; R Kapoor; R P M Saw
Journal:  Eur J Surg Oncol       Date:  2017-05-25       Impact factor: 4.424

4.  Inefficacy of F-18 fluorodeoxy-D-glucose-positron emission tomography scans for initial evaluation in early-stage cutaneous melanoma.

Authors:  Jeffrey D Wagner; Donald Schauwecker; Darrell Davidson; Theodore Logan; John J Coleman; Gary Hutchins; Charlene Love; Stacie Wenck; Joanne Daggy
Journal:  Cancer       Date:  2005-08-01       Impact factor: 6.860

5.  Pediatric melanoma: results of a large cohort study and proposal for modified ABCD detection criteria for children.

Authors:  Kelly M Cordoro; Deepti Gupta; Ilona J Frieden; Timothy McCalmont; Mohammed Kashani-Sabet
Journal:  J Am Acad Dermatol       Date:  2013-02-08       Impact factor: 11.527

6.  Sentinel lymph node biopsy is a prognostic measure in pediatric melanoma.

Authors:  Jina Kim; Zhifei Sun; Brian C Gulack; Mohamed A Adam; Paul J Mosca; Henry E Rice; Elisabeth T Tracy
Journal:  J Pediatr Surg       Date:  2016-03-04       Impact factor: 2.545

7.  Review of diagnostic imaging modalities for the surveillance of melanoma patients.

Authors:  Yan Xing; Kate D Cromwell; Janice N Cormier
Journal:  Dermatol Res Pract       Date:  2011-08-23

8.  TERT Promoter Mutations Are Predictive of Aggressive Clinical Behavior in Patients with Spitzoid Melanocytic Neoplasms.

Authors:  Seungjae Lee; Raymond L Barnhill; Reinhard Dummer; James Dalton; Jianrong Wu; Alberto Pappo; Armita Bahrami
Journal:  Sci Rep       Date:  2015-06-10       Impact factor: 4.379

9.  Genetic and Epigenetic Alterations of TERT Are Associated with Inferior Outcome in Adolescent and Young Adult Patients with Melanoma.

Authors:  Brittani Seynnaeve; Seungjae Lee; Sumit Borah; Yongseok Park; Alberto Pappo; John M Kirkwood; Armita Bahrami
Journal:  Sci Rep       Date:  2017-04-05       Impact factor: 4.379

10.  Prognostic factors for metastasis in cutaneous melanoma.

Authors:  Ana Carolina Figueiredo Pereira Cherobin; Alberto Julius Alves Wainstein; Enrico Antônio Colosimo; Eugênio Marcos Andrade Goulart; Flávia Vasques Bittencourt
Journal:  An Bras Dermatol       Date:  2018 Jan-Feb       Impact factor: 1.896

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.